_(1)_(1)3.png)
Kebijakan Vaksinasi COVID-19 di Indonesia: Sebuah Upaya Dalam Meningkatkan Partisipasi Masyarakat Untuk di Vaksin
Abstract
The government has started the COVID-19 vaccination program in Indonesia, on January 13, 2021, targeting 70% of Indonesia's population. However, in implementing the COVID-19 vaccination nationally, there are various obstacles, such as many people who are afraid of the side effects of vaccines, halal vaccines and paid vaccinations which are rejected by the community. The low level of public confidence in the COVID-19 vaccine is further exacerbated by hoax news about vaccines that are spreading in the community. The purpose of this study is to see how the policies taken by the Indonesian government in increasing public participation for the COVID-19 vaccine. The research method used in this study uses a literature review research method with a qualitative approach. The results of the study show that the Indonesian government's policy in an effort to increase public participation for the COVID-19 vaccine is to apply a COVID-19 vaccine certificate as a requirement in public activities. The use of the COVID-19 vaccine certificate has increased public participation in the vaccine. In addition, the behavior of public officials showing that the COVID-19 vaccine is safe to use after being vaccinated has also increased public participation in the Covid-19 vaccine.
Full Text:
PDF (Bahasa Indonesia)References
CoviAis, R. (2020). Komunikasi Efektif di Masa Pandemi Covid-19: Pencegahan Penyebaran Covid-19 di Era 4.0 (KKN-DR). Makmood Publishing,.
Astuti, N. P., Nugroho, E. G. Z., Lattu, J. C., Potempu, I. R., & Swandana, D. A. (2021). Persepsi Masyarakat terhadap Penerimaan Vaksinasi Covid-19: Literature Review. Jurnal Keperawatan, 13(3), 569–580. https://doi.org/10.32583/keperawatan.v13i3.1363
Bardan, A. B. (2021). Pemerintah akan jadikan sertifikat vaksin sebagai syarat untuk kegiatan publik. Nasional.Kontan.Co.Id. https://nasional.kontan.co.id/news/pemerintah-akan-jadikan-sertifikat-vaksin-sebagai-syarat-untuk-kegiatan-publik
Bayu, D. (2022). Sebanyak 86,9% Penduduk Indonesia Beragama Islam. Data Indonesia.Id. https://dataindonesia.id/ragam/detail/sebanyak-869-penduduk-indonesia-beragama-islam
Cahyani, D. R. (2021). WHO Sempat Kritik Vaksin Berbayar Sebelum Dibatalkan Jokowi, Begini Isinya. TEMPO.CO. https://dunia.tempo.co/read/1484060/who-sempat-kritik-vaksin-berbayar-sebelum-dibatalkan-jokowi-begini-isinya/full&view=ok
Center, K. I., Change.org, & Covid-19, K. (2021). Survei KIC : Mayoritas Masyarakat Tak Setuju Vaksin (Issue September). databoks.katadata.co.id.
Chaterine, R. N. (2021). Survei Median Ungkap Banyak Masyarakat Mau Divaksin Covid-19 Agar Bisa ke Mal hingga Bekerja. Kompas.Com. https://nasional.kompas.com/read/2021/09/09/20255641/survei-median-ungkap-banyak-masyarakat-mau-divaksin-covid-19-agar-bisa-ke?page=all
Corona.jakarta.go.id. (2022). Vaksinasi Booster COVID-19. Corona.Jakarta.Go.Id. https://corona.jakarta.go.id/id/vaksinasi
Covid 19.go.id. (2022). Covid 19.Go.Id. https://covid19.go.id/
Covid19.go.id. (2022). Vaksin COVID-19 Dosis 4: Efektif Tingkatkan Antibodi dan Imunitas. Covid19.Go.Id. https://covid19.go.id/artikel/2022/08/05/vaksin-covid-19-dosis-4-efektif-tingkatkan-antibodi-dan-imunitas
Dewi, S. A. E. (2021). Komunikasi Publik Terkait Vaksinasi Covid 19. Health Care : Jurnal Kesehatan, 10(1), 162–167. https://doi.org/10.36763/healthcare.v10i1.119
Direktorat Jenderal Pencegahan Dan Pengendalian Penyakit. (2021). Program Vaksinasi COVID-19 Mulai Dilakukan, Presiden Orang Pertama Penerima Suntikan Vaksin COVID-19. Kementerian Kesehatan Republik Indonesia. http://p2p.kemkes.go.id/program-vaksinasi-covid-19-mulai-dilakukan-presiden-orang-pertama-penerima-suntikan-vaksin-covid-19/
Fitriani Pramita Gurning, Laili Komariah Siagian, Ika Wiranti, Shinta Devi, & Wahyulinar Atika. (2021). Kebijakan Pelaksanaan Vaksinasi Covid-19 Di Kota Medan Tahun 2020. Jurnal Kesehatan, 10(1), 43–50. https://doi.org/10.37048/kesehatan.v10i1.326
Gandryani, F., & Hadi, F. (2021). Pelaksanaan Vaksinasi Covid-19 Di Indonesia Hak Atau Kewajiban Warga Negara. Rechts Vinding Media Pembinaan Hukum Nasional, 10(1). https://doi.org/10.24912/psenapenmas.v0i0.15162
Handoyo, E. (2012). Kebijakan Publik (Mustrose (Ed.); cetakan 1). Widya Karya.
Indikator. (2021). Siapa Enggan Divaksin?Tantangan Dan Problem Vaksinasi Covid-19 Di Indonesia. Indikator.
Indonesia, C. (2021). Kronologi Riuh Vaksin Berbayar Hingga Dibatalkan Jokowi. CNN Indonesia. https://www.cnnindonesia.com/nasional/20210717094502-20-668905/kronologi-riuh-vaksin-berbayar-hingga-dibatalkan-jokowi
Indonesia, K. K. dan I. R. (2022). Penanganan Sebaran Konten Hoaks Vaksin Covid-19 Rabu (24/08/2022). Kementerian Komunikasi Dan Informatika Republik Indonesia. https://www.kominfo.go.id/content/detail/43879/penanganan-sebaran-konten-hoaks-vaksin-covid-19-rabu-24082022/0/infografis
John W. Creswell. (2008). Educational Research, Planning, Conducting, and Evaluating Quantitative and Qualitative Research (FOURTH EDI). Pearson Education Merrill Prentice Hall.
Survei Penerimaan Vaksin COVID-19 di Indonesia, (2020).
Kementerian Kesehatan RI. (2021). Frequently Asked Question (Faq) Pelaksanaan Vaksinasi Covid-19. In Kementerian Kesehatan RI. kesmas.kemkes.go.id
Nugroho, R. (2018a). public policy (Y. Masda (Ed.); Edisi 6). PT Elex Media Komputindo.
Nugroho, R. (2018b). public policy (Y. Masda (Ed.); Edisi Ke 6). PT Elex media komputindo.
Polri, K. (2021). Kini Sertifikat Vaksin Jadi Syarat Pembuatan dan Perpanjangan SIM di Satlantas Polres Lamteng. KorlantasPolri. https://korlantas.polri.go.id/news/kini-sertifikat-vaksin-jadi-syarat-pembuatan-dan-perpanjangan-sim-di-satlantas-polres-lamteng/
Rachman, F. F., & Pramana, S. (2020). Analisis Sentimen Pro dan Kontra Masyarakat Indonesia tentang Vaksin COVID-19 pada Media Sosial Twitter. Health Information Management Journal, 8(2), 2655–9129.
Rahayu, R. N., & Sensusiyati. (2021). Vaksin covid 19 di indonesia : analisis berita hoax. Intelektiva : Jurnal Ekonomi, Sosial & Humaniora, 2(07), 39–49.
Ramadhan, F. M. (2021). Tiga Alasan Sertifikat Vaksinasi Covid-19 Dijadikan Syarat Akses Tempat Umum. Tempo.Co. https://grafis.tempo.co/read/2767/tiga-alasan-sertifikat-vaksinasi-covid-19-dijadikan-syarat-akses-tempat-umum
Rokom. (2021). Vaksin AstraZeneca Aman, Penghentian Sementara Hanya Pada Kelompok CTMAV547. Sehatnegeriku.Kemkes.Go.Id. https://sehatnegeriku.kemkes.go.id/baca/rilis-media/20210516/4837770/vaksin-astrazeneca-aman-penghentian-sementara-hanya-pada-kelompok-ctmav547/
Rusli, B. (2013). Kebijakan Publik Membangun Pelayanan Publik Yang Responsif (N. M. Wiganda (Ed.); Cetakan 1). Hakim Publishing.
Saptoyo, R. D. A. (2021). WHO Kritik Vaksin Berbayar Indonesia, Ini Alasannya. Kompas.Com. https://www.kompas.com/tren/read/2021/07/16/172900465/who-kritik-vaksin-berbayar-indonesia-ini-alasannya?page=all
Satria, F. B., Khalifa, M., Rabrenovic, M., & Iqbal, U. (2021). Can digital vaccine passports potentially bring life back to “true-normal”? Computer Methods and Programs in Biomedicine Update, 1(172), 100011. https://doi.org/10.1016/j.cmpbup.2021.100011
Tamara, T. (2021). Gambaran Vaksinasi COVID-19 di Indonesia pada Juli 2021. Medula, 11(1), 180–183. http://journalofmedula.com/index.php/medula/article/view/255
Welle, D. (2021). Makin Banyak Negara Hentikan Penggunaan Vaksin AstraZeneca. Deutsche Welle (DW). https://www.dw.com/id/sejumlah-negara-hentikan-penggunaan-vaksin-astrazeneca/a-56850844
Yanwardhana, E. (2022). Menkes Ungkap Biang Kerok Naiknya Kasus Covid-19 di Indonesia. CNBC Indonesia. https://www.cnbcindonesia.com/news/20220612061821-4-346255/menkes-ungkap-biang-kerok-naiknya-kasus-covid-19-di-indonesia
DOI: https://doi.org/10.20527/jpp.v5i1.6940
Refbacks
- There are currently no refbacks.
